ArticleEngineering (Beijing, China)2021
COVID-19 Vaccine Allocation: Modeling Health Outcomes and Equity Implications of Alternative Strategies.
Article in Engineering (Beijing, China), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.Systematic reviews · 2024Pooled it
- Evaluating COVID-19 vaccination policy in Québec (Canada) using a data-driven dynamic transmission model.PLoS computational biology · 2025Article
- Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models.Infectious Disease Modelling · 2024Review
- Exploring the factors influencing the adult population's reluctance to accept the COVID-19 vaccine in Tehran.BMC health services research · 2024Article
- Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models.medRxiv : the preprint server for health sciences · 2024Article
- Causes and costs of global COVID-19 vaccine inequity.Seminars in immunopathology · 2024Review
- Equitable bivalent booster allocation strategies against emerging SARS-CoV-2 variants in US cities with large Hispanic communities: The case of El Paso County, Texas.Infectious Disease Modelling · 2023Article
- A novel mathematical model for prioritization of individuals to receive vaccine considering governmental health protocols.The European journal of health economics : HEPAC : health economics in prevention and care · 2023Article
- Drivers of COVID-19 Vaccine Intent Among Survivors of Adolescent and Young Adult Cancer: a Mixed Method Study.Journal of cancer education : the official journal of the American Association for Cancer Education · 2023Article
- Designing an optimization model for the vaccine supply chain during the COVID-19 pandemic.Expert systems with applications · 2023Article
- An extended picture fuzzy multicriteria group decision analysis with different weights: A case study of COVID-19 vaccine allocation.Socio-economic planning sciences · 2023Article
- Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal.Vaccine · 2022Article
- COVID-19 vaccine distribution planning using a congested queuing system-A real case from Australia.Transportation research. Part E, Logistics and transportation review · 2022Article
- Can vaccine prioritization reduce disparities in COVID-19 burden for historically marginalized populations?PNAS nexus · 2022Article
- Ethical allocation of scarce vaccine doses: The Priority-Equality protocol.Frontiers in public health · 2022Article
- Prioritizing vaccination based on analysis of community networks.Applied network science · 2022Article
- Article
- Geographically targeted COVID-19 vaccination is more equitable and averts more deaths than age-based thresholds alone.Science advances · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given the scarcity of safe and effective COVID-19 vaccines, a chief policy question is how to allocate them among different sociodemographic groups. This paper evaluates COVID-19 vaccine prioritization strategies proposed to date, focusing on their stated goals; the mechanisms through which the selected allocations affect the course and burden of the pandemic; and the main epidemiological, economic, logistical, and political issues that arise when setting the prioritization strategy. The paper uses a simple, age-stratified susceptible-exposed-infectious-recovered model applied to the United States to quantitatively assess the performance of alternative prioritization strategies with respect to avoided deaths, avoided infections, and life-years gained. We demonstrate that prioritizing essential workers is a viable strategy for reducing the number of cases and years of life lost, while the largest reduction in deaths is achieved by prioritizing older adults in most scenarios, even if the vaccine is effective at blocking viral transmission. Uncertainty regarding this property and potential delays in dose delivery reinforce the call for prioritizing older adults. Additionally, we investigate the strength of the equity motive that would support an allocation strategy attaching absolute priority to essential workers for a vaccine that reduces infection-fatality risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.